焦点粘附激酶通过调节4和5基斯脱乙酶的调节促进血管光滑肌细胞的化
Wenjie Tian1,2,3, Kuldeep Singh1, Lova P Kajuluri1
1Cardiovascular Research Center and Cardiology Division of the Heart and Vascular Institute, Boston (W.T., K.S., L.P.K., S.L., K.R., C.J.N., W.J., H.J.B., S.B., K.O., R.H.L., C.B., E.M., H.T., H.H.S., M.S.M., A.L.J., E.L.C., M.E.L., C.L.L.C., R.M.).
焦点粘附激酶 (FAK) 通过调节素脱乙酶 (HDACs) 4和5促进血管化. 针对FAK,HDAC4和HDAC5可能为血管化提供新的治疗方法.
科学领域:
- 血管生物学 血管生物学
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- 血管化是一种活跃的过程,涉及血管光滑肌细胞 (VSMC) 的骨质过渡.
- 焦点粘附激酶 (FAK) 通过调节素脱乙酶 (HDAC) 4和5局部化,影响骨形成.
- 在VSMC中通过HDAC调节在血管化中的FAK的作用仍然不清楚.
研究的目的:
- 研究FAK在VSMC化中的作用.
- 要确定FAK是否通过HDAC4和HDAC5.5调节血管化.
- 探索FAK作为血管化的潜在治疗标.
主要方法:
- 使用了扰动性测定,包括药理抑制和FAK的基因沉默.
- 对VSMC化,迁移和化因子表达的评估影响.
- 研究了抑制HDAC核出口的影响,并分析了人类冠状动脉中的FAK表达.
主要成果:
- HDAC4和HDAC5被确定为血管化的积极调节者.
- 抑制FAK阻断了VSMC化,降低了化因子,并降低了细胞迁移.
- 抑制FAK增强了HDAC4和HDAC5的核定位,并减弱了动脉化.
结论:
- FAK促进VSMC化,部分通过HDAC4和HDAC5化.
- 准FAK,HDAC4和HDAC5为血管化提供了一个潜在的治疗策略.
更多相关视频
11:30A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
相关概念视频
Intracellular Signaling Affects Focal Adhesions
Some...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Regulation of Angiogenesis and Blood Supply
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
cAMP-dependent Protein Kinase Pathways
